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1. Introduction 
Rhinosinusitis with its chronic benign course, failure in antibiotic treatment and acute 
exacerbations, usually require multiple courses of antibiotics or surgical procedures, or both. 
Nowadays, the pathogenic mechanisms of microbes in rhinosinusitis have gradually been 
revealed. Many current hypotheses focus on the formation of biofilms, bacterial 
superantigens, cytokine dysregulation, and abnormalities of cell-mediated immune 
responses (Kilty & Desrosiers, 2008; Zhang et al., 2005, Post et al., 2004).  
“Rhinosinusitis” is a group of disorders characterized by inflammation of the mucosa of the 
nose and the paranasal sinuses. It is presently accepted that rhinosinusitis is initiated with 
an inflammatory insult (viral infection of upper respiratory tract, allergic rhinitis, etc.), 
followed by bacterial or fungal superinfection (Kennedy & Thaler, 1997; van Cauwenberge 
et al., 2006). Most upper respiratory tract infections are self-limited but progression to acute 
illness occurs and progression to chronic disease is common. Because specific treatment 
approaches are crucial for the different types of rhinosinusitis, this review focuses on 
microbiological aspects of rhinosinusitis.   
2. Normal flora of upper respiratory tract 
Most of the surfaces of the upper respiratory tract (including nasal and oral passages, 
nasopharynx, oropharynx, and trachea) are colonized by normal flora. The normal flora of 
human upper respiratory tract is harmless, and usually beneficial for the host. Two main 
functions are played by these bacteria, that are important in maintaining the healthy state of 
the host:  
1. these organisms compete with pathogenic organisms for potential attachment sites, 
2. they often produce substances (toxins or acids) which are bactericidal. 
The nose is colonized predominantly by staphylococci, with Staphylococcus aureus and 
Staphylococcus epidermidis and diphtheroids as the leaders. The most important group of 
microorganisms native to oropharynx are also the alpha-hemolytic streptococci or viridans 
streptococci. This group includes Streptococcus mitis, Streptococcus mutans, Streptococcus 
milleri, and Streptococcus salivarius. It is believed that these bacteria act as antagonists against 
invasion by pathogenic streptococci.   
But normal nasopharynx is not only the primary settlement of saprophytic bacteria. It is  
also the chief carrier of common respiratory pathogens, including Streptococcus pneumoniae, 
Haemophilus influenzae and Moraxella catarrhalis (Baron 1996). 
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3. Acute rhinosinusitis. Epidemiology and predisposing factors 
3.1 Definition 
Sinusitis is inflammation of the sinuses, which are air-filled cavities in the skull. This 
inflammation leads to blockade of the normal sinus drainage pathways (sinus ostia), which 
in turn leads to mucus retention, hypoxia, decreased mucociliary clearance, and 
predisposition to bacterial growth. Acute rhinosinusitis is an inflammatory condition 
involving the paranasal sinuses, as well as the lining of the paranasal passages, and it lasts 
up to 4 weeks, after which the symptoms resolve completely. Sinus infection is defined as 
the invasion and multiplication of microorganisms within a sinus. The etiology can be 
infectious (bacterial, viral, or fungal) or noninfectious (allergic) triggers (Fokkens et al., 2007; 
Thaler & Kennedy, 2008).  
European Position Statement on Rhinosinusitis and Nasal Polyps defines acute 
rhinosinusitis as sudden onset of two or more symptoms, one of which should be either 
nasal blockade/obstruction/congestion or nasal discharge (anterior/posterior nasal dip) 
with facial pain/pressure or reduction or loss of smell (Fokkens et al., 2007).  
3.2 Pathogenic factors of acute rhinosinusitis 
Acute rhinosinusitis occurs when one of the mechanisms essential to sinus clearance breaks 
down. The ostiomeatal complex is particularly vulnerable to inflammatory changes, 
swelling and obstruction. Anatomic variations and other factors generally predispose 
patients to acute bacterial rhinosinusitis by causing inflammation in the ostiomeatal 
complex. Normal ciliary function, intact mucous membranes and normal mucous 
production are required for sinus clearance. Many factors can disturb these functional 
mechanisms predisposing to acute infection (Kennedy & Thaler, 1997; Anon, 2005; Fokkens 
et al., 2007).  
The initial stages of rhinosinusitis comprise inflammatory swelling of the sinus epithelium 
and mucosa, secretion of proinflammatory factors, including cytokines, accumulation of 
inflammatory cells, such as eosinophils and lymphocytes, and obstruction of the sinus ostia 
(Hadley & Siegert, 2004). 
Data shows that viral upper respiratory tract infections and pharyngeal colonization with 
group A streptococci predispose children to acute bacterial rhinosinusitis. The incidence of 
viral infections in acute rhinosinusitis is unknown, but it is estimated that 0.5-5% of viral 
infections lead to sinusitis (Brook et al., 2000; Fokkens et al., 2007).  
Normal mucociliary flow is a key defense mechanism in the prevention of acute 
rhinosinusitis. Viral rhinosinusitis results in the loss of ciliated cells and mucociliary flow 
during the first week of infection. Consequently, the impaired mucociliary function during 
viral rhinosinusitis increases the risk of bacterial superinfection, which, in turn, results in 
further disruption of mucociliary flow (Fokkens et al., 2007; Sande & Gwaltney 2004). 
Exposure to bacterial toxins can also reduce ciliary function. Approximately 10% of cases of 
acute rhinosinusitis result from direct inoculation of the sinus with a large amount of 
bacteria. Bacterial infection causes inflammation and swelling, which leads to increased 
mucus production, reduced air flow through the nasal cavity and mucus congestion in the 
sinuses, enhancing bacterial growth (Hadley & Siegret, 2004). 
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Allergy is another factor that predispose to rhinosinusitis. Allergy can contribute to 
rhinosinusitis through either nasal congestion and subsequent ostial obstruction or direct 
allergic effects on sinus-lining cells. Obstructed sinus ostia, as the results of mucosal swelling 
and edema, may be more prone to infection (Fokkens et al., 2007; Thaler & Kennedy, 2008).  
The other factors that predispose to acute rhinosinusitis are nasal polyposis, deviation of the 
nasal septum and dental procedures. Air pollution, cigarette smoking and overuse of topical 
decongestants impair ciliary action and predispose to rhinosinusitis as well (Fokkens et al., 
2007). 
3.3 Microbiology of acute rhinosinusitis: Viral or bacterial? 
The upper respiratory tract represents a frequent site of infection because it is regularly 
exposed to direct contact and transmission of environmental pollutants and common 
microbes during breathing.  
The most common factor associated with rhinosinusitis is upper respiratory infection, which 
is complicated by bacterial infection. Upper respiratory infections are mainly caused by 
viruses, leading to symptoms of common cold and inflammation of the paranasal sinuses. 
Viral rhinosinusitis has seasonal patterns of occurrence based on the virus involved. 
Rhinovirus is the most common cause of common cold and rhinosinusitis in all age groups, 
accounting for 30–70% of all respiratory illnesses. Other viruses causing upper respiratory 
infections are coronaviruses (7–18%), followed by influenza A and B, adenoviruses, 
parainfluenza viruses, respiratory syncytial viruses (RSV) and enteroviruses, all accounting 
for minor proportions of common cold cases (Thaler & Kennedy, 2008). Viral upper 
respiratory tract infection stimulates increases in inflammation and in the local immune 
response of the nasopharynx and surrounding mucosa. Some viruses, such as influenza 
virus, produce significant mucosal damage. Others promote the local production of 
cytokines and other inflammatory mediators, leading to the signs and symptoms of the 
common cold (Aanan, 2005). Clinically, patients experience a self-limiting illness lasting 3-7 
days.  
Acute bacterial rhinosinusitis complicates approximately 0.5% of adult and 5% pediatric 
cases of viral infections. It is usually a secondary infection resulting from ostiomeatal 
complex obstruction, impaired (delayed or absent) mucociliary clearance and weakened 
mucociliary integrity caused by an acute viral upper respiratory tract infection (Sande & 
Gwaltney, 2004). 
Acute bacterial rhinosinusitis is a clinical condition characterized by nasal congestion, 
purulent rhinorrhea, postnasal dip and facial pain and pressure alone or with associated 
referred pain of the ears or teeth. The syndromes last for 7-14 days but no more than 4 
weeks (Fokkens et al., 2007).  
Several factors may predispose an individual with viral rhinosinusitis to acquire a 
secondary bacterial infection, including viral virulence, nosopharyngeal colonization and 
host immunity. The role of bacteria in acute rhinosinusitis is well defined. Streptococcus 
pneumoniae (20%-45%) and non typable strains of Haemophilus influenzae (22%-35%), are the 
most common pathogenic organisms in acute bacterial rhinosinusitis in adults. Streptococcus 
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pneumoniae (30%-45%), non typable Haemophilus influenzae (20%-28%) and Morraxella 
catarrhalis (20-28%) are reported as predominant in children with acute bacterial 
rhinosinusitis. Until now Staphylococcus aureus has often been considered as a contaminant, 
but a recent data suggests that Staphylococcus aureus is a true pathogen in about 10% of cases 
of acute bacterial rhinosinusitis in adults (Benninger & Manz 2010; Payne, 2007) (Table 1). 
This is not surprising, as all these pathogens can be the parts of normal flora in upper 
respiratory tract. 
The growing resistance to antimicrobial agents of all respiratory tract bacterial pathogens 
has made the management of bacterial rhinosinusitis more difficult.  
Streptococcus pneumoniae are gram-positive, catalase-negative, facultatively anaerobic cocci 
that account for up to 45% of acute bacterial rhinosinusitis cases in adults and children. The 
rise of antimicrobial resistance in Streptococcus pneumoniae is a major concern. The most 
alarming situation is the occurrence of strains with decreased susceptibility to penicillin, 
that was the drug of choice in pneumococcal infections for many years. Penicillin resistance 
means the resistance or decreased susceptibility to other β-lactams. This is applied mostly 
for cephalosporins. Moreover, strains resistant to penicillin are also multi-drug resistant 
(resistance to macrolids, tetracycline, co-trimoxazole). However, they are still susceptible to 
increased doses of amoxicillin (Mazur, 2010; Aanan 2005).  
Haemophilus influenzae is the second commonest agent of bacterial acute rhinosinusitis 
responsible for about 25% of rhinosinusitis cases in children. Studies have reported the 
presence of this bacterium in up to a third of adult rhinosinusitis patients as well. Beta-
lactamase production is the mechanism of antimicrobial resistance for this organism. Of 
isolates from the paranasal sinus, 32.7% were found to be β-lactamase–positive. Other 
reports suggest a rate of 44%. 
Moraxella catarrhalis is mainly isolated from children. Over 75% of all children harbor this 
bacterium, which causes about 25% of rhinosinusitis cases. The strains of Moraxella 
catarrhalis commonly (more than 90% strains) produce  β-lactamases all over the world 
(Mazur, 2010; Aanan, 2005). 
The widespread antibiotic resistance among pathogens that are agents of rhinosinusitis 
allows for the persistence of infection and the development of chronic rhinosinusitis (CRS) 
(Thaler & Kennedy, 2008). 
Nowadays it is noted that the vaccination of children with heptavalent conjugate 
pneumococcal vaccine results in significant shift in causative pathogens of acute bacterial 
rhinosinusitis. While the proportion of Streptococcus pneumoniae declined by 11%, the 
proportion of Haemophilus influenzae increased by 6%. A small increase in the isolation of 
other pathogens (Moraxella catarrhalis, Staphylococcus auresus and Streptococcus pyogenes) was 
also noted (Brook et al., 2006). Widespread use of conjugate pneumococcal vaccine has led to 
decreasing incidence of pneumococcal acute bacterial rhinosinusitis, which may have 
implications for treatment recommendations for these infections (Benninger, 2008). This 
pathogen shift may also have an important effect on the severity of acute bacterial 
rhinosinusitis. It is documented, that patients with acute bactericidal rhinosinusitis infected 
with Streptococus pneumoniae have more significant symptoms and worse radiographic 
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findings than those infected with Haemophilus influenzae. This fact could result in less severe 
symptoms and radiographic findings in patients with acute form of the disease (Benninger 






Rhinovirus 15%-40% 1% 
Adenovirus ---- 2% 
Influenzae virus 5% ---- 
Parainfluenzae virus 3% 2% 
Bacteria   
Streptococcus pneumoniae 20%-45% 30%-45% 
Haemophilus influenzae* 22%-35% 20%-28% 
Moraxella catarrhalis 0%-8% 20%-28% 
Staphylococcus aureus 0%-10% 0%-8% 
Streptococcus pyogenes 0%-7% 3%-9% 
* non typable strains 
Table 1. The commonest pathogens in acute rhinosinusitis. Data are from (Thaler & 
Kennedy, 2008; Sande & Gwaltney, 2004). 
3.4 Microbiology diagnostics of acute rhinosinusitis 
Bacterial and viral rhinosinusitis are difficult to differentiate on clinical grounds. On the 
other hand, bacterial rhinosinusitis must be distinguished from viral infection and treated 
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with antibiotics, because serious complications may be associated when bacterial 
superinfection develops. (Hytönen et al., 2000; Herrmann & Forsen 2004). The reference 
standard for the diagnosis of acute bacterial rhinosinusitis is sinus puncture with culture 
and recovery of bacteria in high density (≥ 104 colony forming units/mL) (Hart, 2007). 
Although sinus aspiration with the possible bacterial culture is the “gold standard” for the 
diagnosis of acute bacterial rhinosinusitis, it is not recommended in general practice. The 
reasons are that the procedure is invasive, time-consuming and potentially painful for the 
patient and can only be performed by a specialist as it requires a local anestethic. However, 
the results of sinus aspiration correlate with clinical and radiographic findings in patients 
with acute respiratory symptoms. 
The most widely used diagnostic procedures for acute rhinosinusitis are signs and 
symptoms, supported by radiographic findings. Some experts believe that bacteriological 
cultures from the posterior parts of nasal cavity and nasopharyngeal aspirates best identify 
those patients with bacterial superinfection (Anan, 2005).  
Because of the difficulty associated with distinguishing viral from bacterial rhinosinusitis, 
the diagnosis of acute bacterial rhinosinusitis is mostly reserved for patients who experience 
rhinosinusitis symptoms (eg, sinus pain, tooth pain, nasal congestion) for more than 7 days 
(Hart, 2007). 
3.5 Current recommendations for diagnosing acute rhinosinusitis in children 
Although sinus aspiration is the “gold standard” for the diagnosis of acute bacterial 
rhinosinusitis, it is not recommended method for routine diagnosis of bacterial sinus 
infections in children. According to recommendations of American Academy of Pediatrics 
the diagnosis of acute bacterial rhinusitis is based on clinical criteria in children who present 
with upper respiratory
 
symptoms that are either persistent or severe (American Academy of 
Pediatrics, 2001). 
Persistent symptoms are symptoms of upper respiratory tract infection that last longer than 10 
days to 14 days, but less than 30 days. Such symptoms include nasal or postnasal
 
discharge, 
daytime cough (which may be worse
 
at night), or both.  
Severe symptoms include a temperature of at least 39ºC and purulent nasal discharge 
present concurrently for at least 3 to 4 consecutive days in a child who seems ill. In this 
clinical presentation, the duration of symptoms is not important, and antimicrobial 
treatment is recommended to be started as soon as possible (American Academy of 
Pediatrics, 2001). 
American Academy of Pediatrics has taken the position that, in children six years and 
younger who are at the peak age for developing acute bacterial sinusitis, a diagnosis can be 
made without performing imaging studies. However, controversy exists about the need for 
radiographs to confirm acute sinusitis in children older than six years with persistent 
symptoms and for children of any age with severe symptoms (American Academy of 
Pediatrics, 2001). The American College of Radiology recommends that the diagnosis be 
made on clinical criteria and that radiographs be used only in patients who do not recover 
or who worsen during the course of antimicrobial therapy (McAlister et al., 2000). 
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CT scans of the paranasal sinuses should be performed only when surgery is being 
considered. CT scans are indicated in children with complications of acute bacterial sinus 
infection or those with very persistent or recurrent infections that are not responsive to 
medical therapy (McAlister et al., 2000; American Academy of Pediatrics, 2001). 
4. Chronic rhinosinusitis 
4.1 Definition 
Chronic rhinosinusitis can be defined as a group of disorders characterized by inflammation 
of the mucosal lining of the nasal cavity and para-nasal sinuses lasting for at least 12 weeks. 
Symptoms are much more subtle then with acute rhinosinusitis. In order to diagnose 
chronic rhinosinusitis, patients are required to have 2 of the following symptoms for at least 
12 consecutive weeks: (1) anterior and /or posterior mucopurulent drainage, (2) nasal 
obstruction and (3) hyposmia or anosmia but also objective evidence of sino-nasal 
inflammation on both endoscopy and radiological imaging with computerised  tomography. 
Fever is not typically observed. According to the definitions of the European Position Paper 
on Rhinosinusitis and Nasal Polyps, chronic rhinosinusitis and nasal polyposis are 
considered as one disease entity, in which nasal polyposis forms a subgroup of chronic 
rhinosinusitis (Fokkens et al., 2007).  
Chronic rhinosinusitis is mostly diagnosed in association with predisposing conditions such 
as asthma, allergy, dental disease, cystic fibrosis, polyposis and immunodeficiency 
syndrome (Thaler & Kennedy, 2008; Kennedy & Thaler, 1997). 
It has been postulated that chronic rhinosinusitis evolves from acute rhinosinusitis, but this 
has never been definitively proven. Also, the role of bacterial infection in chronic 
rhinosinusitis is less clear than in acute rhinosinusitis (Thaler & Kennedy, 2008). 
4.2 Pathogenic factors 
Chronic rhinosinusitis is now considered a multi-factorial disease involving multiple host 
and environmental factors. This factors has been broadly categorized into extrinsic or 
non-host related factors and intrinstic or host related factors. Extrinsic factors that have 
been implicated as etiologies contributing to the development of CRS include viral, 
bacterial, and/or fungal colonization and their associated pathogenicity (biofilms, 
superantigens, osteitis and non-IgE mediated eosinophilic inflammation) as well as 
exposure to inhaled substances, such as cigarette smoke or allergens. Intrinsic factors 
found to be associated with chronic rhinosinusitis include anatomic/structural 
abnormalities, genetic abnormalities, such as cystic fibrosis or primary ciliary dyskinesia 
and disorders in innate and cell mediated immune system (van Cauwenberg & van 
Hoeche, 2006). 
The presence of intracellular Staphylococcus aureus in epithelial cells of the nasal mucosa has 
been suggested to play a significant risk for recurrent episodes of rhinosinusitis due to 
persistent bacterial clonotypes, which appear refractory to antimicrobial and surgical 
therapy (Plouin-Gaudon et al., 2006). 
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4.3 Bacteria and chronic rhinosinusitis 
The microbiology of chronic rhinosinusitis differs when comparing to acute rhinosinusitis. 
Study shows that in patients with chronic rhinosinusitis, pathogens such as Staphylococcus 
aureus, coagulase negative streptococci and anaerobic Gram-negative bacteria replace the 
pathogens commonly found in bacterial acute rhinosinusitis. The prevalence of anaerobic 
species can be explained by physiologic changes in the sinuses including reduced oxygen 
tension and pH, thereby creating a favorable environment for these organisms (van 
Cauwenberge et al., 2006; Thaler & Kennedy 2008).  
4.3.1 Controversy regarding the role of bacteria in chronic rhinosinusitis 
In contrast with the well-established roles of microbes in the etiology of acute sinusitis with 
Streptococcus pneumoniae, Moraxella catarrhalis and non typable Haemophilus influenzae strains 
as the most common pathogens involved, the exact roles of all of these microbes in the 
etiology of chronic sinusitis are uncertain. Until now, there have been many controversies 
concerning the microbial involvement in chronic sinusitis (Kilty & Desrosiers, 2008; Thaler 
& Kennedy, 2008). 
It has been postulated that in many cases of chronic rhinosinusitis bacteria can be present 
only as non-pathogens. This conclusion arose from the observation, that the sinuses are not 
sterile as once taught. Also, the fact that poor correlation is observed between clinical 
findings, microbiology and antibiotic therapy confirmed the limited role of bacteria in 
chronic rhinosinustis (Post et al., 2004; van Cauwenberge et al., 2006). 
Much of the disagreement may be explained by methodology used. Different studies used 
different sampling methods as well as different methods to detect bacteria and quantify 
bacterial load (culture vs. PCR). It is thought that these differences may not only affect the 
culture yield rate but also the type of organism isolated (Kilty & Desrosiers, 2008). 
Nowadays, the role of bacteria in chronic rhinosinusitis have gradually been revealed. 
Several theories raised to explain the patophysiology of this chronic disease. It is currently 
thought that chronic rhinosinusitis is an immunological inflammatory disease caused 
simultaneously or singly by several factors, such as: immune conditions, intrinsic upper 
airway factors, Staphylococcus aureus superantigens, and persistent biofilm presence and/or 
osteitis of the sinus wall (Bezerra et al., 2009). In this paper, the role of bacterial 
superantigens and biofilm will be overviewed. 
4.3.2 Bacterial superantigens 
The superantigen hypothesis of chronic rhinosinusitis suggests that bacterial toxins within 
the nose stimulate massive oligoclonal expansion of T-cell populations with subsequent 
eosinophil recruitment and tissue inflammation (Seiberling, Grammer, et al., 2005). 
In the pathogenesis of chronic rhinosinusitis with nasal polyposis, this theory have been 
supported by several studies. Superantigens are microbial derived toxins capable of 
triggering massive T cell proliferation and activation. They have the ability to activate up to 
30% of the T-cell population in contrast to the conventional antigen response, which 
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activates only 0.01% of all T cells. In the acute setting superantigens may lead to the sudden 
and massive release of Th1 and Th2 cytokines which accounts for their acute toxicity 
(Llewelyn et al., 2002; Seiberling, Conley et al., 2005).  
Evidence accumulates that Staphylococcus aureus colonizes a high percentage of patients with 
chronic rhinosinusitis with nasal polyposis. Staphylococcus aureus can secrete at least 19 
different exotoxins capable of functioning as superantigens, triggering massive T-cell 
activation, and induces an overproduction of immunoglobulin E, as well as a severe 
possibly steroid-insensitive eosinophilic inflammation.(Zhang et al., 2005). 
Understanding how superantigens overstimulate the immune system is crucial to set up 
rational therapeutics for chronic rhinosinusitis. Patients with eosinophilic chronic 
rhinosinusitis remain the most refractory to medical and surgical intervention (Seiberling, 
Conley et al., 2005). 
4.3.3 Bacterial biofilm 
One possible mechanism for the chronic nature of rhinosinusitis is the involvement of 
bacterial biofilms. Recent publications estimate that at least 65% of all chronic bacterial 
infections involve biofilms (Kilty & Desrosiers, 2008; Post et al., 2004). 
Biofilms are three-dimensional bacterial aggregates embedded together in the slimelike 
matrix composed of polysaccharides, nucleic acids and proteins (extracellular polymeric 
substances). Bacteria in biofilm are under different transcriptional regulation and are thus 
phenotypically different than free living bacteria. The vast majority of bacteria, regardless of 
species, exist within a biofilm, including those that are important in rhinosinusitis, such as 
Haemophilus influenzae, Streptococcus pneumoniae and Staphylococcus aureus (Kilty & 
Desrosiers, 2008).  
The formation of a bacterial biofilm occurs in several concurrent steps. The initiating 
event is the attachment of individual bacterial cells to a surface by weak reversible 
physical forces. Differentiation of the biofilm after attachment depends on cell-to-cell 
signaling, which facilitate the binding of other bacteria to the infected surface. This 
process initiates phenotypic changes within the bacteria to irreversibly secure the initial 
attachment.  
The second stage involves irreversible attachment between specific microbial adhesins and 
the surface. One important element of this process is polysaccharide intracellular adhesion 
(PIA), that mediates the cell-cell interactions in some staphylococcal biofilms.  
Cell aggregation into microcolonies and their division ensure the continued growth of the 
biofilm into complex structure. When biofilms reach their critical mass, single bacterium or 
aggregates of bacteria  can disperse into the surrounding environment. After detachment 
bacteria can be redistributed to other areas of the host surface, where further biofilm growth 
can be initiated (Post et al., 2004). 
Owing to its multicellular nature, biofilms provide bacteria with distinct advantages. An 
adventage that is extremely important clinically is that bacteria in biofilms are very resistant 
to antibiotics, capable of surviving antibiotic concentrations thousands of time greater than 
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free living bacteria (Post et al., 2004). Also, biofilm formation makes the bacteria resistant to 
host defense mechanisms, because the aggregation of bacteria into biofilm cannot be 
phagocytized, humoral immune system is not effective against aggregated bacteria as well.  
The same properties that make bacteria within biofilm resistant to antibiotics and to the 
attack of immune system also make it difficult to identify them in laboratory by routine 
methods. Bacterial biofilms have been found in patients with chronic rhinosinusitis by 
scanning electron microscopy (SEM), transmission electron microscopy (TEM), confocal 
scanning laser microscopy, or fluorescent in situ hybridization (FISH) successfully. The use 
of PCR-based techniques demonstrates a high detection rate of bacterial pathogens in 
chronic diseases when comparing with conventional culture technique (Kilty & Destrosiers, 
2008).  
The fact that bacterial existence in the form of biofilm in probably preferred in chronic 
infections, there is growing evidence for the presence of bacterial biofilms in chronic 
rhinosinusitis (Kilty & Desrosiers, 2008).  
If bacterial biofilms are the cause of certain cases of chronic rhinosinusitis, then the 
treatment paradigms will have to be changed. Novel nonantimicrobial therapies may have 
clinical applications to prevent and destabilize biofilms.  
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